Related Experiment Video
Updated: Jun 3, 2025
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Coronary health index based on immunoglobulin light chains to assess coronary heart disease risk with machine
Wenbo Ren1, Zichen Zhang1, Yifei Wang1,2
1Department of Clinical Laboratory, The First Hospital of Jilin University, Changchun, 130000, China.
Background:
Recent studies suggest a connection between immunoglobulin light chains (IgLCs) and coronary heart disease (CHD). However, current diagnostic methods using peripheral blood IgLCs levels or subtype ratios show limited accuracy for CHD, lacking comprehensive assessment and posing challenges in early detection and precise disease severity evaluation. We aim to develop and validate a Coronary Health Index (CHI) incorporating total IgLCs levels and their distribution. Additionally, we aim to evaluate its effectiveness by integrating patient data and using machine learning models through diagnostic trial.
Methods:
The CHI was developed and combined with other clinical data. Nine machine learning models were screened to identify optimal diagnostic performance, with the XGBoost model emerging as the top performer. Performance was assessed based on accuracy, sensitivity, and its ability to identify severe CHD cases characterized by complex lesions (SYNTAX score > 33).
Results:
The XGBoost model demonstrated high accuracy and sensitivity in diagnosing CHD, with an area under the curve (AUC) of 0.927. It also accurately identified patients with severe CHD, achieving an AUC of 0.991. An online web tool was introduced for broader external validation, confirming the model's effectiveness.
Conclusions:
Combining the CHI with the XGBoost model offers significant advantages in diagnosing CHD and assessing disease severity. This approach can guide clinical interventions and improve large-scale CHD screening.
